Levels of Regulation
Gene expression is controlled at multiple levels
Gene expression can be regulated at every step from DNA to functional protein: chromatin structure (is the gene physically accessible?), transcription initiation (is the gene being copied into RNA?), RNA processing (which pre-mRNA sequences are kept?), mRNA stability (how long does the mRNA persist?), translation (is the mRNA being read into protein?), and post-translational modification (is the protein being activated, localized, or degraded?). Control at multiple levels provides redundancy and precision.
Tx
Transcriptional regulation โ promoters, enhancers, transcription factors
The primary level of gene regulation is at transcription initiation. Three elements work together:
Promoter: The DNA sequence immediately upstream of the gene where RNA polymerase binds to begin transcription. The core promoter contains the TATA box (~25โ30 bp upstream of the transcription start site in many eukaryotic genes) where TATA-binding protein (TBP) and the transcription initiation complex assemble.
Enhancers: Regulatory DNA sequences that can be thousands of base pairs away from the promoter (upstream, downstream, or even within introns) and greatly increase transcription when bound by activator transcription factors. Enhancers work by DNA looping โ the enhancer-bound activators physically contact the promoter-bound transcription machinery even across large genomic distances.
Silencers: Regulatory sequences that decrease transcription when bound by repressor transcription factors.
Transcription factors (TFs): Sequence-specific DNA-binding proteins that recognize enhancer/silencer sequences and recruit coactivators or corepressors to modulate RNA polymerase activity. The combination of TFs bound at any gene's regulatory sequences determines the cell type-specific pattern of expression.
Memory trick: Promoter = where RNA pol binds (near the gene). Enhancer = booster far away (works by DNA looping). TF activators = turn genes on. TF repressors = turn genes off. Combinatorial TF logic = why different cells express different genes from the same DNA.
Chrom
Chromatin remodeling โ opening and closing the genome
DNA wrapped tightly around histones in condensed chromatin (heterochromatin) is inaccessible to transcription factors and RNA polymerase โ it cannot be transcribed. Chromatin remodeling complexes use ATP to slide or evict nucleosomes, making the DNA accessible. This is a prerequisite for transcription.
Histone modifications regulate chromatin compaction: Histone acetylation (by histone acetyltransferases/HATs) โ acetyl groups on lysine residues neutralize the positive charge of histones โ weaken DNA-histone interaction โ open chromatin โ transcription permissive. Histone deacetylation (by HDACs) โ compacted chromatin โ gene silencing. H3K4me3 (trimethylation of histone H3 lysine 4) โ active promoters. H3K27me3 (Polycomb-mediated methylation of H3 lysine 27) โ gene silencing. The combination of histone modifications at any locus constitutes the 'histone code' that determines transcriptional activity.
Memory trick: Acetylation = loosens histones = open chromatin = ACTIVE gene. Deacetylation = tightens = SILENT. HATs add acetyl (activate). HDACs remove acetyl (silence). 'HAT tips its hat to open up.' HDAC inhibitors (vorinostat) used in cancer.
Epi
Epigenetics โ heritable changes without DNA sequence change
Epigenetics refers to heritable changes in gene expression that do not involve changes to the DNA sequence itself โ they are changes in how the DNA is packaged and read. Two major epigenetic mechanisms:
DNA methylation: Addition of a methyl group to cytosine residues (specifically CpG dinucleotides โ cytosine followed by guanine) by DNA methyltransferases (DNMTs). Methylation of CpG islands (clusters of CpG dinucleotides) in gene promoters is strongly associated with gene silencing. Methylation is maintained through DNA replication by DNMT1 (maintenance methyltransferase), which recognizes hemimethylated DNA (one strand methylated, one new strand unmethylated) after replication and adds methyl groups to the new strand. This allows epigenetic patterns to be inherited by daughter cells.
Imprinted genes: X-inactivation, Prader-Willi/Angelman syndromes are examples where differential DNA methylation of parental chromosomes silences one allele.
Epigenetic inheritance across generations: Some epigenetic marks survive gametogenesis and are transmitted to offspring โ 'transgenerational epigenetic inheritance.' Evidence from the Dutch Hunger Winter: grandchildren of women who experienced severe caloric restriction during pregnancy showed altered metabolic epigenomes โ epigenetic effects of famine transmitted across generations.
Memory trick: DNA methylation at CpG island in promoter = SILENCED gene. Unmethylated CpG island = ACTIVE gene. DNMT = adds methylation. TET enzymes = remove methylation. Cancer often has global hypomethylation (activating proto-oncogenes) and focal hypermethylation (silencing tumor suppressors).
miRNA
Post-transcriptional regulation โ miRNA and RNA stability
Gene expression is also regulated after transcription:
MicroRNAs (miRNAs): Small (~22 nucleotide) non-coding RNAs that bind to partially complementary sequences in the 3'UTR of target mRNAs โ either inhibit translation or trigger mRNA degradation. ~2,000 human miRNAs regulate the majority of protein-coding genes. miRNAs are critical regulators of development, cell differentiation, and tumorigenesis. miRNA dysregulation is common in cancer โ some miRNAs act as oncogenes (onco-miRs), others as tumor suppressors.
mRNA stability: mRNA half-lives vary from minutes to hours, determining how long translation can continue from a given transcript. AU-rich elements (AREs) in mRNA 3'UTRs signal rapid degradation. mRNA stabilization by RNA-binding proteins (like those protecting ฮฒ-globin mRNA in red blood cells โ where long mRNA half-life is needed because mature RBCs have no nucleus and cannot make new mRNA) is another regulatory mechanism.
Memory trick: miRNA = small RNA that silences mRNA. Binds 3'UTR โ blocks translation or degrades mRNA. miRNAs regulate most genes. Tumor suppressors are often miRNAs silenced in cancer.
๐ฌ Applied Scenario โ Gene Regulation in Development and Cancer
Gene regulation is the molecular basis of development, cell identity, and cancer:
A
Cancer as a gene regulation disease. Many cancers are not caused by mutations in protein-coding sequences but by mutations in regulatory elements โ enhancers, promoters, or genes encoding transcription factors. Activation of proto-oncogene MYC through enhancer hijacking (when a chromosomal rearrangement places MYC near a strong enhancer from another gene) is a common mechanism in lymphoma. Loss of DNA methylation at CpG islands upstream of proto-oncogenes (global hypomethylation in cancer) can transcriptionally activate oncogenes without any mutation in the coding sequence itself.
B
HDAC inhibitors in cancer therapy. Histone deacetylase inhibitors (vorinostat/Zolinza, romidepsin/Istodax, panobinostat/Farydak) are approved for certain cancers (cutaneous T-cell lymphoma, multiple myeloma). By blocking histone deacetylation, they maintain histones in an acetylated (open) state โ transcriptional activation of genes involved in differentiation and apoptosis โ cancer cells differentiate or die. HDAC inhibitors demonstrate that targeting epigenetic machinery โ not just mutated genes โ is a viable cancer treatment strategy.
C
Cell reprogramming โ transcription factors make cells change identity. Shinya Yamanaka's discovery that introducing just four transcription factors (Oct4, Sox2, Klf4, c-Myc) into adult cells reprograms them to pluripotent stem cells (iPSCs) demonstrated the extraordinary power of transcription factors to completely reorganize gene expression patterns. The four factors activate pluripotency genes while silencing differentiation genes โ rewriting the cell's entire epigenetic landscape. This won the Nobel Prize in 2012 and proves that cell identity is maintained by transcription factor activity, not by irreversible changes to DNA sequence.
D
miRNA therapeutics. Dysregulated miRNAs in cancer are therapeutic targets. Let-7 family miRNAs are tumor suppressors that target RAS family oncogenes โ they are frequently downregulated in cancer, removing a brake on RAS activity. Delivering let-7 miRNA mimics to tumors restores this brake. Conversely, miR-21 is an onco-miR (elevated in many cancers) that silences tumor suppressor PTEN โ antisense oligonucleotides (antagomirs) targeting miR-21 are in development to restore PTEN expression. RNA-based therapeutics targeting miRNAs represent a new class of drugs.
๐ Exam Application
Gene regulation questions appear in genetics, cell biology, and molecular biology courses:
1. Transcriptional regulation levels: Promoter (near gene, RNA Pol binding). Enhancer (far away, activator TFs, works by DNA looping). Silencer (repressor TFs). Combinatorial TF logic determines cell-type specific expression.
2. Chromatin state: Acetylated histones = open = active. Deacetylated = closed = silent. H3K4me3 = active promoters. H3K27me3 = silenced. HATs activate; HDACs silence. HDAC inhibitors = cancer therapy.
3. DNA methylation: CpG island methylation in promoter = gene silenced. Unmethylated = active. DNMT adds methyl. Cancer: hypomethylation activates oncogenes; hypermethylation silences tumor suppressors.
4. miRNA: ~22 nt small RNA. Binds 3'UTR of target mRNA โ translation inhibition or mRNA degradation. Regulates most genes. Dysregulated in cancer.
5. Epigenetic inheritance: Methylation maintained through replication by DNMT1. Histone modifications maintained by reader-writer complexes. Some marks transmitted to offspring.
โ ๏ธ The Most Common Gene Regulation Mistakes
Enhancers can be UPSTREAM or DOWNSTREAM of the gene they regulate โ even within introns. Students assume enhancers are always upstream (5' of the gene). Enhancers can be thousands of base pairs upstream or downstream, or even within introns of the regulated gene. What makes them enhancers is not their position but their ability to stimulate transcription when bound by activator transcription factors โ they contact the promoter by DNA looping regardless of their position.
DNA methylation of CpG islands in PROMOTERS silences genes โ methylation in gene bodies can activate transcription. Students apply 'methylation = silencing' universally. This is only true for CpG islands in gene promoter regions. DNA methylation in the gene body (coding region) is actually positively correlated with active transcription in some contexts. The silencing effect is specific to promoter methylation.
miRNAs do not completely block translation โ they typically reduce it. Students sometimes describe miRNA action as 'blocking' gene expression completely. Most miRNA effects are partial โ they reduce translation efficiency and/or increase mRNA degradation, typically producing 2โ10 fold reductions in protein output. Fine-tuning gene expression, not binary switching, is the typical miRNA role.
โ Quick Self-Test
1. What is the difference between a promoter and an enhancer?
2. How does histone acetylation affect gene transcription?
3. What is DNA methylation and how does it regulate gene expression?
4. How do miRNAs regulate gene expression?
5. What is epigenetic inheritance and give one example?
Answers:
1. A promoter is the DNA sequence immediately upstream of a gene where RNA polymerase and the transcription initiation complex bind to begin transcription โ it is fixed in position relative to the gene. An enhancer is a regulatory DNA sequence that can be thousands of base pairs away from the promoter (upstream, downstream, or within introns) and dramatically increases transcription when bound by activator transcription factors โ it contacts the promoter machinery through DNA looping.
2. Histone acetylation (addition of acetyl groups to lysine residues on histone tails, catalyzed by HATs) neutralizes the positive charge of histones, weakening their interaction with negatively charged DNA. This loosens chromatin structure, making DNA more accessible to transcription factors and RNA polymerase โ increases transcription. Histone deacetylation (by HDACs) removes acetyl groups โ histones regain positive charge โ chromatin compacts โ gene silencing.
3. DNA methylation is the addition of a methyl group to cytosine residues at CpG dinucleotides, catalyzed by DNA methyltransferases (DNMTs). Methylation of CpG islands (clusters of CpGs) in gene promoters strongly correlates with gene silencing โ methylated promoters recruit methyl-CpG binding proteins that attract histone deacetylases and chromatin compaction machinery. Unmethylated CpG island promoters are associated with active transcription.
4. MicroRNAs (miRNAs) are small (~22 nucleotide) non-coding RNAs that bind to partially complementary sequences in the 3' untranslated region (3'UTR) of target mRNAs. Binding leads to either translational repression (ribosome cannot efficiently translate the mRNA) or mRNA degradation, reducing protein output from the target gene. Each miRNA can regulate hundreds of target mRNAs; ~2,000 human miRNAs collectively regulate the majority of protein-coding genes.
5. Epigenetic inheritance is the transmission of gene expression states (not DNA sequence changes) from parent cell to daughter cells (mitotic epigenetic inheritance) or from parents to offspring (transgenerational epigenetic inheritance). Example: DNA methylation patterns are maintained through replication by DNMT1, which recognizes hemimethylated DNA (one strand methylated, one new strand unmethylated after replication) and adds methyl groups to the unmethylated strand, faithfully propagating the methylation pattern to daughter cells.